BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11087198)

  • 1. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types.
    Liaw KL; Hildesheim A; Burk RD; Gravitt P; Wacholder S; Manos MM; Scott DR; Sherman ME; Kurman RJ; Glass AG; Anderson SM; Schiffman M
    J Infect Dis; 2001 Jan; 183(1):8-15. PubMed ID: 11087198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.
    Rousseau MC; Pereira JS; Prado JC; Villa LL; Rohan TE; Franco EL
    J Infect Dis; 2001 Dec; 184(12):1508-17. PubMed ID: 11740725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estimation of HPV infection presence in cytological smears in a group of asymptomatic women].
    Łukaszuk K; Liss J; Zalewski J; Roter M; Brzóska B; Debniak J
    Wiad Lek; 2001; 54(9-10):508-15. PubMed ID: 11816294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
    Castle PE; Schiffman M; Burk RD; Wacholder S; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1394-9. PubMed ID: 12433717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.
    Perrons C; Kleter B; Jelley R; Jalal H; Quint W; Tedder R
    J Med Virol; 2002 Jun; 67(2):246-52. PubMed ID: 11992586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV detection in cervical cancer patients in northern Poland.
    Dybikowska A; Licznerski P; Podhajska A
    Oncol Rep; 2002; 9(4):871-4. PubMed ID: 12066224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent and sequential acquisition of different genital human papillomavirus types.
    Thomas KK; Hughes JP; Kuypers JM; Kiviat NB; Lee SK; Adam DE; Koutsky LA
    J Infect Dis; 2000 Oct; 182(4):1097-102. PubMed ID: 10979905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.
    Gravitt PE; Lacey JV; Brinton LA; Barnes WA; Kornegay JR; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Zaino R; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):95-100. PubMed ID: 11219778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.
    Moscicki AB; Ellenberg JH; Farhat S; Xu J
    J Infect Dis; 2004 Jul; 190(1):37-45. PubMed ID: 15195241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
    Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
    Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of genital human papillomavirus detection in a US population.
    Peyton CL; Gravitt PE; Hunt WC; Hundley RS; Zhao M; Apple RJ; Wheeler CM
    J Infect Dis; 2001 Jun; 183(11):1554-64. PubMed ID: 11343204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
    J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of HPV DNA detection by MY09/11 PCR methods.
    Castle PE; Schiffman M; Gravitt PE; Kendall H; Fishman S; Dong H; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A; Schussler JE; Burk RD
    J Med Virol; 2002 Nov; 68(3):417-23. PubMed ID: 12226831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis of human papillomavirus: comparison between cervical and vaginal sampling.
    Finan RR; Irani-Hakime N; Tamim H; Almawi WY
    Infect Dis Obstet Gynecol; 2001; 9(2):119-22. PubMed ID: 11495553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.
    Giuliano AR; Papenfuss M; Abrahamsen M; Denman C; de Zapien JG; Henze JL; Ortega L; Brown de Galaz EM; Stephan J; Feng J; Baldwin S; Garcia F; Hatch K
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1129-36. PubMed ID: 11700260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
    J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular variants of human papillomaviruses types 16, 18, and 45 in tumors of the uterine cervix in Mexico].
    Lizano M; García-Carrancá A
    Gac Med Mex; 1997; 133 Suppl 1():43-8. PubMed ID: 9504102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.